| Literature DB >> 34203489 |
Da-Jeong Chang1, Hwi-Young Cho2, Seyoung Hwang1, Nayeon Lee1, Chunggab Choi1, Hyunseung Lee3, Kwan Soo Hong3, Seung-Hun Oh4, Hyun Sook Kim4, Dong Ah Shin5, Young Wook Yoon6, Jihwan Song1,7.
Abstract
The most common type of spinal cord injury is the contusion of the spinal cord, which causes progressive secondary tissue degeneration. In this study, we applied genetically modified human neural stem cells overexpressing BDNF (brain-derived neurotrophic factor) (F3.BDNF) to determine whether they can promote functional recovery in the spinal cord injury (SCI) model in rats. We transplanted F3.BDNF cells via intrathecal catheter delivery after a contusion of the thoracic spinal cord and found that they were migrated toward the injured spinal cord area by MR imaging. Transplanted F3.BDNF cells expressed neural lineage markers, such as NeuN, MBP, and GFAP and were functionally connected to the host neurons. The F3.BDNF-transplanted rats exhibited significantly improved locomotor functions compared with the sham group. This functional recovery was accompanied by an increased volume of spared myelination and decreased area of cystic cavity in the F3.BDNF group. We also observed that the F3.BDNF-transplanted rats showed reduced numbers of Iba1- and iNOS-positive inflammatory cells as well as GFAP-positive astrocytes. These results strongly suggest the transplantation of F3.BDNF cells can modulate inflammatory cells and glia activation and also improve the hyperalgesia following SCI.Entities:
Keywords: brain-derived neurotrophic factor (BDNF); contusion; functional recovery; neural stem cells; spinal cord injury
Year: 2021 PMID: 34203489 DOI: 10.3390/ijms22136970
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923